Elkem had a mixed Q1, with EBITDA of NOK898m 3% above consensus but 9% below our estimate, while EPS of NOK-0.3 missed both our forecast and consensus. However, we remain optimistic about Elkem’s outlook, contingent on a successful divestment of its Silicones assets, and have made minor adjustments to our 2026–2027e EPS. We reiterate our BUY and NOK30 target price.
We estimate Q1 EBITDA of NOK983m, driven by near-term margin improvement in Silicones, partly offset by our lowered expectations for Silicon due to still-weak market conditions, along with additional headwinds from production curtailments and maintenance work. We have reduced our 2026–2027e EPS by 3%. We reiterate our BUY and NOK30 target price.
Q4 EBITDA was cNOK1.2bn, in line with our estimate and consensus. The company proposed a DPS of NOK0.3 for 2024, which was above our forecast of NOK0 and consensus of NOK0.09. We have made minor adjustments to our 2025–2026e EPS, and are 6% above consensus for 2026e EPS. We reiterate our BUY and NOK30 target price.
Q4 EBITDA was cNOK1.2bn, in line with our estimate and consensus. The company proposed a DPS of NOK0.3 for 2024, which was above our forecast of NOK0 and consensus of NOK0.09. We have made minor adjustments to our 2025–2026e EPS, and are 6% above consensus for 2026e EPS. We reiterate our BUY and NOK30 target price.
We have upgraded Elkem to BUY (HOLD), as we see upside potential from a possible divestiture of the Silicones business, following its announced strategic review. We believe the Silicon Products and Carbon Solutions divisions could be worth cNOK20bn, in addition to the potential cash consideration for Silicones. Cash returns should come up with sharply lower capex. In our opinion, the main risk is the divestment not materialising. Our Q4e EBITDA is NOK1.2bn, and we have raised our target price to...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.